Endoscopy in Benign Ampullary Neoplasms: Not Just for Diagnosis Anymore - PowerPoint PPT Presentation

1 / 77
About This Presentation
Title:

Endoscopy in Benign Ampullary Neoplasms: Not Just for Diagnosis Anymore

Description:

Endoscopy in Benign Ampullary Neoplasms: Not Just for Diagnosis Anymore – PowerPoint PPT presentation

Number of Views:61
Avg rating:3.0/5.0
Slides: 78
Provided by: ValuedGate242
Category:

less

Transcript and Presenter's Notes

Title: Endoscopy in Benign Ampullary Neoplasms: Not Just for Diagnosis Anymore


1
(No Transcript)
2
Endoscopic Management of ObesityNot just for
surgical complications anymore
  • AGA Institute Fellows Nutrition Course 2007
  • Rosemont/Chicago, Illinois November 9, 2007
  • John A. Martin, M.D.
  • Associate Professor of Medicine and Surgery
  • Director of Endoscopy
  • Northwestern University Feinberg School of
    Medicine Chicago, Illinois

3
Role of Endoscopy in the Management of Obesity
  • Management of bariatric surgical complications
  • Endoscopically-delivered bariatric interventions
    (investigational)
  • NOTES (investigational)

4
Endoscopic Management of Bariatric Surgical
Complications
5
Case PresentationRYGB
  • 37 y/o F (WV)
  • S/P laparoscopic RYGB surgery for morbid obesity
  • Lost 35 lbs in 4 wks
  • 5 wks postop
  • Vomiting
  • Epigastric pain
  • Whats going on? What do you do?

6
Why is this important?
7
Obesity Trends Among U.S. AdultsBRFSS, 1990,
1998, 2006
(BMI ?30, or about 30 lbs. overweight for 54
person)
1998
1990
2006
No Data lt10 1014
1519 2024 2529
30
8
Obesity Burden of Disease
  • 300,000 deaths annually
  • 100 billion per year in direct and indirect
    costs (17 of total health care costs)
  • Comorbidities are protean
  • Hypertension
  • Diabetes
  • Cardiomyopathy
  • Sleep Apnea
  • DJD
  • Psychosocial
  • etc

9
Obesity Treatment
  • Why surgery for obesity?
  • Conservative treatments dont work (i.e., largely
    unsuccessful in maintaining long-term weight loss
    in morbid obesity)
  • Diets
  • Behavioral modification
  • Exercise
  • No medications that are highly-effective but safe
  • Bariatric surgery is effective durable
  • 50 reduction in excess body weight within 18
    to 24 months
  • Operations
  • Vertical-banded gastroplasty (VBG)
  • Lap Band
  • Gastric Bypass
  • BPD

10
Estimated Number of Bariatric Operations in the
US 1992-2003
120
gt 100,000
100
80
Thousands of Operations per Year
60
40
20
0
1992
1994
1996
1998
2000
2002
Year
11
(No Transcript)
12
Restrictive Procedures
Gastric pouch
Subcutaneous port
Adjustable Lap band
Silastic ring/band
Illustration John Pandolfino, MD
VBG
Lap Band
13
Malabsorptive Procedures
Gastric pouch
Subcutaneous port
Adjustable Lap band
Silastic ring/band
BPD
BPD Duodenal Switch
Illustration John Pandolfino, MD
14
Roux-en-Y Gastric Bypass
Gastric Pouch
Anastomosis
Remnant Stomach
Jejunojejunostomy
Illustration John Pandolfino, MD
15
(No Transcript)
16
Post-operative Complications
Perioperative mortality of bariatric surgery is
less than 1 but morbidity can be substantial
17
Anastomotic Complications
  • Marginal Ulcer- 5-15
  • On jejunal side--probably acid- related
  • Stomal Ulcer- 5-15
  • On gastric pouch side--probably ischemia-related
  • Stomal Stricture- 12
  • Stoma size usually greater than 1cm when created
  • Stricture defined arbitrarily as inability to
    pass 27 Fr (9mm) scope
  • May be associated with marginal/stomal ulceration

Endoscopic view of stomal stricture with
ulceration
18
Anastomotic Complications RYGB
  • Pouch
  • Stomal ulcer
  • Anastomosis
  • Marginal ulcer
  • Anastomotic stricture
  • Remnant stomach
  • PUD
  • Duodenum
  • PUD
  • Roux anastomosis
  • Bleeding
  • Stricture
  • Ulceration

Illustrator John Pandolfino, MD
19
ENDOSCOPY POST-RYGB
20
Endoscopy Post-Bariatric Surgery
  • Symptomatic indications
  • Vomiting /- nausea
  • Abdominal pain (usually epigatric)
  • Weight gain/decelerated weight loss
  • GI bleeding
  • Hematemesis
  • Melena
  • Jaundice (possibly)

21
Endoscopic Appearance of Common Anastomotic
Complications
  • Anastomotic ulcer
  • Anastomotic stricture

22
EGD Forward-viewing endoscopy
Images Pentax Medical, Inc.
23
Endoscopic Stricture DilationTTS (Mylar
Gruntzig) Balloons
Images Boston Scientific, Inc.
Wilson-Cook Medical, Inc.
24
Treatment Options Ulcer
  • Treat medically
  • PPI
  • Sucralfate
  • Avoid NSAIDS ASA
  • Eradicate H. pylori
  • Schirmer, et al., 2002 marginal ulcers with
    without preop HP screening
  • screen 2.4
  • -screen 6.8
  • Plt0.05

Anastomotic Ulcer (Marginal)
25
Treatment Options Stricture
Treat Endoscopically
Dilation with a through-the-scope balloon
dilator
Gastrograffin swallow
From Martin and Pandolfino, Curr Gastroenterol
Rep 2005.
26
  • Details
  • 14 patients
  • 23 dilations
  • 15-25 Fr balloons
  • 1-3 total dilations
  • Results
  • At µ18 mos
  • r7-30 mos
  • All responded
  • No complications

27
Case Presentation 1 RYGB
  • 37 y/o F (WV)
  • S/P RYGB surgery
  • Lost 35 lbs in 4 wks
  • 5 wks postop
  • Vomiting
  • Epigastric pain
  • Whats going on? What do you do?

28
Case Presentation 1 RYGB
  • EGD is performed

29
Case Presentation 2 RYGB
  • 57 y/o F
  • S/P RYGB surgery 9 mos prior to transfer to
    Northwestern Memorial Hospital
  • Complication 1 gastropleural fistula requiring
    thoracotomy drainage
  • Complication 2 chronic gastrocutaneous fistula
    requiring operative drainage debridement, now
    with persistent output
  • Unable to tolerate oral intake now on TPN

30
Pre UGS 1
31
Pre UGS 2
32
Gastric pouch
Fistula tract
Anastomosis
Jejunum
Pre UGS 3
33
Pre UGS 4
34
Pre UGS 5
35
Pre UGS 6
36
Pre UGS 7
37
EGD 1
38
EGD 1
39
EGD 1
40
EGD 1
41
EGD 1
42
EGD 1
43
EGD 1
44
EGD 1
45
EGD 1
46
EGD 1
47
EGD 1
48
EGD 1
49
3 weeks later
EGD 2
50
EGD 2
51
EGD 2
52
serial, graduated dilation
EGD 2
53
EGD 2
54
In another 3 weeks, give it another go
EGD 3
55
EGD 3
56
EGD 3
57
EGD 3
58
Post UGIS
59
Post UGIS
60
Fistula closed
Anastomosis widely patent
Post UGIS
61
Case Resolution
  • At 3 months follow up
  • Her fistula had closed
  • Her skin wound had healed
  • She was tolerating solid oral intake without
    difficulty
  • and she remains well today

62
DO WE REALLY KNOW WHAT WERE DOINGYET?
63
How about a bit of data
64
Endoscopic Balloon Dilation in RYGB
65
Do we know what were doing?Our recent
retrospective data
  • 540 pts with RYGB at NMH
  • 112 underwent EGD (21) for nausea, vomiting,
    inability to take po, dysphagia, hematemesis
  • 80 had abnormal findings
  • 39 have anastomotic ulcers
  • 19 have stricture
  • 22 have ulcer and stricture
  • Only 20 have neither ulcers nor strictures
  • All strictures were treated successfully with TTS
    balloon dilation without complication
  • No ulcers or strictures have required reoperation

66
Do we know what were doing?Our recent
prospective data from
  • 24 RYGB patients had EGD in recent 4-month period
    for N/V and / or epigastric pain
  • 79 have ulcers or strictures
  • 71 have anastomotic ulcers
  • 8 have stricture
  • Only 21 have neither ulcers nor strictures
  • All were treated with PPI or EGD dilation
  • None have required reoperation
  • So far, no predictive value for pain vs N/V in
    differentiating ulcer from stricture

67
Opportunities to change the paradigm
  • Prophylactic PPIs for all RYGB patients post-op?
    If so, for how long?
  • Empiric PPI therapy instead of for all RYGB
    patients with N/V epig pain ?
  • What is the optimum dilation diameter?
  • What is the degree of acidity in the gastric
    pouch?
  • Should patients routinely undergo concomitant
    cholecystectomy?
  • What can be done endoscopically to treat
    recurrent weight gain post RYGB?
  • What can be done endoscopically to treat suture
    line fistulas and leaks?

68
Future Directions
  • Anastomotic enlargement, gastric pouch stretching
  • Bulking agents polymer injectables
  • Ligation plication
  • Fistulas suture line leaks
  • Endoscopic clipping
  • Ligation devices
  • Bulking agents polymer injectables

Images Microvasive, Inc.
Wilson-Cook Medical, Inc. Olympus
America, Inc.
69
More Future Directions
  • Anastomotic ulcers
  • Postop prophylactic acid suppression
  • Postop sucralfate
  • Suture material / staple material / technique
  • Prevention of gallstone complications
  • Concomitant cholecystectomy
  • Postop prophylactic ursodiol
  • Combined management of non-anastomotic strictures
    (e.g., restriction band stenosis)
  • Endoscopic management in complications of the
    afferent Roux limb
  • Expanded endoscopic role in Lap-Band
    complications?

70
Endoscopic Management of Obesity
71
Endoscopically-delivered BariatricInterventions
  • All are investigational
  • Gastric space-occupying devices
  • GEGB
  • BIB
  • Non balloon-based space-occupying devices
  • Gastric anatomical modification
  • Endoluminal gastric plication techniques
  • Endoscopic gastrojejunostomy
  • Luminal sleeves

72
NOTES in Bariatrics
73
NOTES in Bariatrics
  • All investigational in animal models
  • NOTES correlates to existing bariatric surgery
  • Roux-en-Y gastric bypass
  • Gastrojejunostomy
  • Gastroplasty

74
Wrapping it up
  • Change is opportunity
  • New operations create new
  • anatomy and new complications
  • Minimally invasive surgery interfaces
  • constantly with interventional endoscopy
  • Both create opportunities for high-impact
    endoscopy
  • New technology novel concepts are spawning new
    endoscopic techniques to manage bariatric
    surgical complications and to deliver definitive
    endoscopic bariatric solutions
  • Medical surgical colleagues are already at
    work, together, seamlessly, in a team-approach to
    advance anatomical solutions to treat obesity

75
Fighting disease in chicago
THANK YOU FOR YOUR INTEREST!
76
INTERVENTIONAL ENDOSCOPY NORTHWESTERN UNIVERSITY
77
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com